ConductScience.org, home

Paper33488583

Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance.

Lee SK and 12 others. Front Immunol, 2020. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance. Papers, record 33488583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33488583

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance.
PubMed
Journal
Front Immunol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.6
iCite
Revised in PubMed
2021-06-22
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee SKSoon Kyu
2Park MJMin-Jung
3Jhun JYJoo Yeon
4Beak JAJin-Ah
5Choi JWJeong Won
6Rye JYJae-Yoon
7Jang JWJeong Won
8Bae SHSi Hyun
9Yoon SKSeung Kew
10Choi HJHo Joong
11You YKYoung Kyoung
12Cho MLMi-La
13Choi JYJong Young

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HomeostasisMajor topic
MetforminMajor topic
T-Lymphocytes, RegulatoryMajor topic
TacrolimusMajor topic
Th17 CellsMajor topic
Adolescent
Animals
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Cell Proliferation
Cells, Cultured
Drug Therapy, Combination
Female
Graft vs Host Disease
Humans
Leukocytes, Mononuclear
Lymphocyte Activation
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131884044Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.Biochem Pharmacol2020https://conductscience.org/library/papers/31884044PubMed
229175009Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity.Clin Res Hepatol Gastroenterol2018https://conductscience.org/library/papers/29175009PubMed
326615097Treg Cell Differentiation: From Thymus to Peripheral Tissue.Prog Mol Biol Transl Sci2015https://conductscience.org/library/papers/26615097PubMed
427126953
Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs.
Transl Res2016https://conductscience.org/library/papers/27126953PubMed
529545795Serial Monitoring of Immune Markers Being Represented Regulatory T Cell/T Helper 17 Cell Ratio: Indicating Tolerance for Tapering Immunosuppression after Liver Transplantation.Front Immunol2018https://conductscience.org/library/papers/29545795PubMed
628584086IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28584086PubMed
731965710Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus-based immunosuppression with basiliximab induction.Am J Transplant2020https://conductscience.org/library/papers/31965710PubMed
822994804Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients.Am J Transplant2012https://conductscience.org/library/papers/22994804PubMed
930118680Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.Mol Cell2018https://conductscience.org/library/papers/30118680PubMed
1025624476Immune-mediated antitumor effect by type 2 diabetes drug, metformin.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/25624476PubMed
1130633591Effects of tacrolimus (FK506) and mycophenolate mofetil (MMF) on regulatory T cells and co-inhibitory receptors in the peripheral blood of human liver allograft patients.Immunopharmacol Immunotoxicol2019https://conductscience.org/library/papers/30633591PubMed
1217446564Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells.Stem Cells2007https://conductscience.org/library/papers/17446564PubMed
1331319067Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1.Eur J Pharmacol2019https://conductscience.org/library/papers/31319067PubMed
1425214721Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17/Treg balance and osteoclastogenesis.Mediators Inflamm2014https://conductscience.org/library/papers/25214721PubMed
1529915588Metformin and Autoimmunity: A "New Deal" of an Old Drug.Front Immunol2018https://conductscience.org/library/papers/29915588PubMed
1617438575Graft-versus-host disease.Nat Rev Immunol2007https://conductscience.org/library/papers/17438575PubMed
179723432Tacrolimus is superior to cyclosporine in liver transplantation.Transplant Proc1998https://conductscience.org/library/papers/9723432PubMed
1823205589
The imbalance of T helper 17/regulatory T cells and memory B cells during the early post-transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression.
Immunology2013https://conductscience.org/library/papers/23205589PubMed
197523946A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.N Engl J Med1994https://conductscience.org/library/papers/7523946PubMed
208569826Metformin.N Engl J Med1996https://conductscience.org/library/papers/8569826PubMed

Download CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42256058Enhanced ocular delivery of tacrolimus via cationic nanoliposomes: Mitigating inflammation and rebalancing Th17/Treg responses in dry eye disease.Mater Today Bio2026https://conductscience.org/library/papers/42256058PubMed
41953033Metformin use and the risk of incident immune-mediated diseases in patients with type 2 diabetes: a population-based cohort study.Front Immunol2026https://conductscience.org/library/papers/41953033PubMed
41898542Liver Transplantation Following Immune Checkpoint Inhibitor Therapy: What Do We Need to Know from Clinical and Immunological Perspective?Int J Mol Sci2026https://conductscience.org/library/papers/41898542PubMed
41695459De novo Inflammatory Bowel Disease following Liver and Heart Transplantation: A Case Series Exploring the Role of IL-23 Pathway-Targeted Therapy.Inflamm Intest Dis2026https://conductscience.org/library/papers/41695459PubMed
40134277Immunotherapy for hypertensive end-organ damage: a new therapeutic strategy.Essays Biochem2025https://conductscience.org/library/papers/40134277PubMed
39754054Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions.Mol Med2025https://conductscience.org/library/papers/39754054PubMed
39215078Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab.Sci Rep2024https://conductscience.org/library/papers/39215078PubMed
39062560Metformin Restrains the Proliferation of CD4+ T Lymphocytes by Inducing Cell Cycle Arrest in Normo- and Hyperglycemic Conditions.Biomolecules2024https://conductscience.org/library/papers/39062560PubMed
38764823Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19.World J Gastrointest Oncol2024https://conductscience.org/library/papers/38764823PubMed
37886013Old drug, new tricks: the utility of metformin in infection and vaccination responses to influenza and SARS-CoV-2 in older adults.Front Aging2023https://conductscience.org/library/papers/37886013PubMed
37688662Metformin induces tolerogenicity of dendritic cells by promoting metabolic reprogramming.Cell Mol Life Sci2023https://conductscience.org/library/papers/37688662PubMed
36902432An Immunological Perspective on the Mechanism of Drug Induced Liver Injury: Focused on Drugs for Treatment of Hepatocellular Carcinoma and Liver Transplantation.Int J Mol Sci2023https://conductscience.org/library/papers/36902432PubMed
36879838The Therapeutic Effect of Tacrolimus in a Mouse Psoriatic Model is Associated with the Induction of Myeloid-derived Suppressor Cells.Rheumatol Immunol Res2022https://conductscience.org/library/papers/36879838PubMed
36091841The molecular pathogenesis of triptolide-induced hepatotoxicity.Front Pharmacol2022https://conductscience.org/library/papers/36091841PubMed
35662580Protection by metformin against severe Covid-19: An in-depth mechanistic analysis.Diabetes Metab2022https://conductscience.org/library/papers/35662580PubMed
35437510The Association between Regulatory T Cell Subpopulations and Severe Pneumonia Post Renal Transplantation.J Immunol Res2022https://conductscience.org/library/papers/35437510PubMed
35418987Patient-Derived Avatar Mouse Model to Predict the Liver Immune Homeostasis of Long-Term Stable Liver Transplant Patients.Front Immunol2022https://conductscience.org/library/papers/35418987PubMed
34822394Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD).Metabolites2021https://conductscience.org/library/papers/34822394PubMed
34360634Potential Therapeutic Approaches through Modulating the Autophagy Process for Skin Barrier Dysfunction.Int J Mol Sci2021https://conductscience.org/library/papers/34360634PubMed
34220860Regulatory T Cells in GVHD Therapy.Front Immunol2021https://conductscience.org/library/papers/34220860PubMed

See all 22 cited byDownload CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33488583

GET https://conductscience.org/api/papers/v1/33488583/cited_by?page=2